Table 1. Patient characteristics.
| Patients | N= 65 |
|---|---|
| Male/female | 38/27 |
| Median age (Q1-Q3) | 72 Years (70-77) |
| >70 Years | 48 (74%) |
| Performance status (N,%) | |
| 0 | 20 (31%) |
| 1 | 37 (58%) |
| >1 | 7 (11%) |
| NA | 1 |
| Median WBC count (Q1-Q3) | 2.3 × 109/L (1.6-4.7) |
| Median platelet count (Q1-Q3) | 43 × 109/L (19-73) |
| Median marrow blast percentage (Q1-Q3) | 31% (20-53) |
| Disease subsets (N, %) | |
| Previously untreated AML | 42 (65%) |
| Relapsed/refractory AML | 13 (20%) |
| High-risk MDS | 10 (15%) |
| Cytogenetics (N, %) | |
| Standard | 28 (48%) |
| Unfavorable * | 30 (52%) |
| NA | 7 |
*
unfavorable karyotypes were defined as −7, del(7q), −5, 3q abnormality, or complex (5 anomalies or more); NA: not available.